Drug Topics

JULY 6, 2023

Researchers concluded that older patients with stable MS can stop taking disease-modifying therapy because risk of relapse is so small.

247

247

PharmaVoice

JULY 6, 2023

New lawsuits challenging the Inflation Reduction Act’s price negotiation program hit the government with multiple Constitution-based challenges.

246

246

Drug Topics

JULY 6, 2023

Other research has suggested that SNRIs can lead to DNA damage, which the investigators said may be the avenue by which the drugs affect lung cancer risk.

247

247

Fierce Pharma

JULY 6, 2023

After becoming chairman of the powerful Senate Health, Education, Labor and Pensions Committee earlier this year, Sen. | After becoming chairman of the powerful Senate Health, Education, Labor and Pensions Committee earlier this year, Sen. Bernie Sanders, I-Vermont—a longtime opponent of Big Pharma—has become even more ubiquitous in his efforts to reduce drug prices.

135

135

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

JULY 6, 2023

The Humira biosimilar is a tumor necrosis factor (TNF) blocker and was approved by the FDA in 2021.

FDA 247

FDA 247

Pharmacy Times

JULY 6, 2023

The benefits of the survey can stretch beyond assessing the parental acceptability of mental health screenings in children and can suggest areas of optimization in providing these screenings more widely and effectively in the future.

132

132

Pharmacy Times

JULY 6, 2023

The safety and efficacy of long-term benzodiazepine use beyond the recommended timeframe is not well understood.

123

123

STAT

JULY 6, 2023

The STAT Diversity and Inclusion Committee is proud to present STAT’s inaugural Diversity and Inclusion Report. Here, we share the self-reported gender and racial/ethnic demographics of our staff from STAT’s inception in 2015 through 2022. This report presents an opportunity to reaffirm STAT’s commitment to becoming the most diverse media company covering the life sciences and health care.

112

112

Pharmacy Times

JULY 6, 2023

Lecanemab-irmb is the first amyloid beta-directed antibody to be converted from an accelerated approval to a traditional approval for the treatment of Alzheimer disease.

FDA 123

FDA 123

Fierce Healthcare

JULY 6, 2023

Stanford Medicine and the Department of Veterans Affairs (VA) unveiled plans Friday to collaborate on a project that will bring a new National Cancer Institute-designated joint cancer care and rese | Stanford Medicine and the VA unveiled plans on Friday to collaborate on a project that will bring a new National Cancer Institute-designated joint cancer care and research center to the VA Palo Alto campus.

Department of Veterans Affairs 111

Department of Veterans Affairs 111

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

JULY 6, 2023

Nonpharmacologic and nonopioid treatments associated with improvements in pain and/or function that appear comparable to opioid treatments.

123

123

Pharmaceutical Technology

JULY 6, 2023

Lifera, Arabio and Sanofi have signed a memorandum of understanding (MOU) to bolster manufacturing of vaccines in Saudi Arabia.

Vaccines 111

Vaccines 111

Pharmacy Times

JULY 6, 2023

mRNA-1345 is a vaccine indicated for the prevention of respiratory syncytial virus-associated lower respiratory tract disease and acute respiratory disease.

Vaccines 123

Vaccines 123

Drug Store News

JULY 6, 2023

The business could be worth as much as $800 million.

106

106

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

JULY 6, 2023

Despite recommendations for adults to receive lung cancer screenings, rates have remained low compared with other cancer screening programs.

118

118

Drug Store News

JULY 6, 2023

AI capabilities for retail are growing and now is the time for experimentation and strategic investments.

105

105

Fierce Pharma

JULY 6, 2023

It’s official: Roughly half a year after the FDA granted an accelerated nod to Eisai and Biogen’s new Alzheimer’s disease med lecanemab, the companies have converted that green light into a full-fl | With a full approval in hand, Leqembi has become the first treatment shown to reduce the rate of disease progression and slow cognitive and functional decline in adults with Alzheimer’s disease under the FDA's traditional approval pathway.

FDA 105

FDA 105

Outsourcing Pharma

JULY 6, 2023

This yearâs CPHI South East Asia is expecting a surge in international partnering with organizers expecting a record attendance of 8,000 visitors including a significant number from overseas â doubling last yearâs figures.

102

102

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

STAT

JULY 6, 2023

Traumatic brain injury multiplies the risk of major depression eightfold. While the emotional trauma of whatever caused such deep damage may be understandable, from a blast in a war zone to a blow on the playing field, there’s a physiological component, too, that neuroscientists have long suspected but have been unable to identify. “As clinicians, a lot of us had a gut feeling that [TBI-associated depression] is a different disease,” said Shan Siddiqi, a Harvard Medical Scho

Medical Schools 101

Medical Schools Hospitals 101

pharmaphorum

JULY 6, 2023

Changing Faces: Agency, consultancy, and investor hires from June 2023 Mike.

98

98

STAT

JULY 6, 2023

The Food and Drug Administration on Thursday granted full approval to the first therapy for Alzheimer’s disease clearly shown to slow the cognitive decline associated with the disease — a milestone in treatment, even if the benefits are modest. The drug, called Leqembi , was developed by Eisai , the Japanese pharmaceutical company, and sold in partnership with Biogen.

FDA 101

FDA Pharmaceutical Companies Pharmaceutical Companies 101

Pharmaceutical Technology

JULY 6, 2023

The ICMRA says evidence from more than 13 billion global vaccine doses shows good safety amid “dangerous” false information.

Vaccines 98

Vaccines 98

STAT

JULY 6, 2023

The partnership that would shape Eli Lilly into one of the biggest success stories in the pharmaceutical industry began with conversations around a relatively minor acquisition. At the time, David Ricks was running Lilly’s U.S. business and was part of the team charged with evaluating Avid Radiopharmaceuticals, which Lilly would go on to purchase in 2010 for a paltry $300 million — couch change for a multibillion-dollar firm.

101

101

PharmExec

JULY 6, 2023

Senior editor Fran Pollaro chats with Sharlene Jenner, vice president of engagement strategy, Abelson Taylor about the transformative impact and ethical considerations of AI in the pharmaceutical industry, emphasizing its potential in data analysis and marketing, while also highlighting the pioneering work of AI companies in advancing drug discovery.

98

98

STAT

JULY 6, 2023

Drinking water from nearly half of U.S. faucets likely contains “forever chemicals” that may cause cancer and other health problems, according to a government study released Wednesday. The synthetic compounds known collectively as PFAS are contaminating drinking water to varying extents in large cities and small towns — and in private wells and public systems, the U.S.

Compounding 101

Compounding 101

Drug Store News

JULY 6, 2023

Several beauty trends will be revealed at PLMA’s 2023 annual Private Label Trade Show, Nov. 12-14 in Chicago.

Labelling 98

Labelling 98

STAT

JULY 6, 2023

At some point this summer, the drugmaker Novo Nordisk will release results from a closely watched study that, if successful, could further uncork demand for new obesity medications, streamline insurance coverage for the therapies, and demonstrate long-lasting health benefits. The Select trial, as the study is called, is the first large, randomized trial to test whether long-term treatment with a weight loss drug can meaningfully improve patients’ cardiovascular health.

Insurance Coverage 98

Insurance Coverage Insurance 98

Drug Store News

JULY 6, 2023

The sister companies have expanded their suite of clinical management and stop-loss solutions to help self-funded plans maintain affordable pharmacy benefits.

Clinic Management 98

Clinic Management 98

STAT

JULY 6, 2023

WASHINGTON – If you live in this city, you’re probably awash in pharmacy benefit manager ads — whether you’re listening to an NPR podcast, reading the New York Times, streaming “Yellowstone,” or watching the U.S. Open Golf Championships. It doesn’t matter if it’s 5 a.m., primetime, or 11 p.m.; in between ads for dog joint supplements and the “Barbie” movie, you will inevitably learn about these middlemen of the prescription dr

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Insurance 98

PharmExec

JULY 6, 2023

Pharma is built to overcome, but focus on fundamentals remains key.

98

98

STAT

JULY 6, 2023

The trade group for generic drug companies has filed a lawsuit alleging a Minnesota law that is designed to provide transparency into prescription drug pricing is unconstitutional, the latest effort to push back against states attempting to lower the cost of medicines. In its lawsuit , the Association for Accessible Medicines claimed the law is an “unconstitutional overreach,” because it gives the state the power to regulate interstate commerce and apply Minnesota law to prices cha

98

98

pharmaphorum

JULY 6, 2023

In our penultimate video from ASCO 2023, Editor in Chief Jonah Comstock touches base with Biofourmis Chief Operating Officer Jaydev Thakkar. Biofourmis works with pharma on accelerating drug development and with post-market monitoring of approved drugs.

98

98

STAT

JULY 6, 2023

Mercy Philadelphia Hospital was planning on shutting down. Losing Mercy, a safety-net hospital serving a predominantly low-income and Black community, would have created a health care desert in West Philadelphia. “It would have been easy for us to just absorb it into our existing hospital beds,” said Kevin Mahoney, CEO of the University of Pennsylvania Health System.

Hospitals 98

Hospitals 98